Hongyu Kuang

机构：Dalian Medical University, Second Affiliated Hospital of Chongqing Medical University, Chongqing Medical University · ORCID：0000-0001-7502-8321

发表论文 4 篇 · 总被引 57 次 · h-index 3

代表论文

• Jinlida for Diabetes Prevention in Impaired Glucose Tolerance and Multiple Metabolic Abnormalities (2024 · JAMA Internal Medicine · 被引 33)
• Liraglutide Alleviates Diabetic Atherosclerosis through Regulating Calcification of Vascular Smooth Muscle Cells (2022 · Disease Markers · 被引 12)
• RNF150 suppresses papillary thyroid carcinoma with ASK1 ubiquitination presenting a direct target via inactivating p38 signaling axis (2023 · Cell Biology International · 被引 10)
• Valine acts as an early biomarker and exacerbates pathological cardiac hypertrophy by impairing mitochondrial quality control (2025 · Atherosclerosis · 被引 2)